03:53 AM EDT, 09/11/2025 (MT Newswires) -- LB Pharmaceuticals (LBRX) said Wednesday it has priced an upsized initial public offering of 19 million shares at $15 per share for total proceeds of $285 million.

LB Pharmaceuticals has also granted underwriters a 30-day option to purchase up to 2.9 million additional shares.

The shares are expected to begin trading on Nasdaq on Thursday under the ticker symbol "LBRX," and the offering is expected to close on Friday, the company said.